Clinical radiobiology of stage T2-T3 bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical radiobiology of stage T2-T3 bladder cancer

Published:2004-09 Issue:1 Volume:60 Page:60-70
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Majewski Wojciech,Maciejewski Boguslaw,Majewski Stanislaw,Suwinski Rafal,Miszczyk Leszek,Tarnawski Rafal

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference40 articles.

1. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation;Greven;Cancer,1990

2. The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy;Lara;Radiother Oncol,1998

3. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer;Maciejewski;Radiother Oncol,1991

4. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder;Mameghan;Int J Radiat Oncol Biol Phys,1995

5. The management of invasive transitional cell carcinoma of the bladder;Mameghan;Cancer,1992

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Trimodal therapy vs radical cystectomy in patients with muscle‐invasive bladder cancer: a systematic review and meta‐analysis of comparative studies;BJU International;2024-04-15

3. Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications;Anticancer Research;2022-07-26

4. The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments;Clinical Genitourinary Cancer;2022-02

5. Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer;Technology in Cancer Research & Treatment;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3